Jove
Visualize
Contact Us

Related Concept Videos

Intralumenal Vesicles and Multivesicular Bodies01:38

Intralumenal Vesicles and Multivesicular Bodies

3.7K
Intraluminal vesicles (ILVs) are small vesicles 50-80 nm in diameter formed during the maturation of early endosomes. A specialized endosome containing numerous ILVs is called a multivesicular body (MVB). ILVs contain internalized molecules such as antigens, nucleic acids, proteins, and metabolites. Some of these molecules are released from the MVBs inside exosomes and are transported to other cells. Other MVBs contain molecules that are retained in the ILVs and are later degraded within the...
3.7K
Vesicular Tubular Clusters01:45

Vesicular Tubular Clusters

2.6K
After budding out from the ER membrane, some COPII vesicles lose their coat and fuse with one another to form larger vesicles and interconnected tubules called vesicular tubular clusters or VTCs. These clusters constitute a compartment at the ER-Golgi interface known as ERGIC (Endoplasmic Reticulum Golgi Intermediate Compartment). The ERGIC is a mobile membrane-bound cargo transport system that sorts proteins secreted from ER and delivers them to the Golgi.
With the help of motor proteins such...
2.6K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

2.1K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.1K
Overview of Secretory Vesicles01:33

Overview of Secretory Vesicles

8.7K
Secretory vesicles, also known as dense core vesicles (DCVs), are membrane-bound vesicles that transport secretory proteins, such as hormones or neurotransmitters. Regulated secretory vesicles transport proteins from the trans-Golgi network to the exterior of the cell. Proteins present in regulated secretory vesicles are required to be rapidly exocytosed in large amounts upon a specific stimulus.
Various proteins regulate the aggregation of molecules inside the secretory vesicles. Chromogranins...
8.7K
Cancer Cell Migration through Invadopodia01:35

Cancer Cell Migration through Invadopodia

2.4K
Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
2.4K
Cell Motility through Blebbing01:16

Cell Motility through Blebbing

2.0K
Blebs are a type of membrane protrusion formed by the internal hydrostatic pressure of the cytoplasm. Blebs are observed in several cell types, including fibroblasts, immune cells, and single-celled organisms like the amoeba. The primary function of blebs is cell locomotion and apoptosis, but they are also found during necrosis and cell division. The life cycle of a bleb comprises an initiation phase followed by the expansion and retraction phases.
Blebbing Through the Matrix
In multicellular...
2.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A ribonucleotide carbohydrate system (iRNC) enhances antigen presentation and controls glioblastoma.

Theranostics·2026
Same author

Vimentin in the tumor microenvironment: orchestrating invasion, immunity, and metabolism.

European journal of cell biology·2025
Same author

Targeting immunosuppressive myeloid cells via implant-mediated slow release of small molecules to prevent glioblastoma recurrence.

Nature biomedical engineering·2025
Same author

Anisomelic acid promotes proteasomal degradation of HPV16 E6 via E3 ligase recruitment: A mass spectrometry-based interactome study.

Journal of proteomics·2025
Same author

Pharmacokinetics, metabolism, and toxicity of anisomelic acid and ovatodiolide: Guiding route of administration in preclinical studies.

European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences·2025
Same author

Cytoskeletal crosstalk in macrophages: Vimentin drives ECM remodeling in tumor invasion and tissue plasticity.

Developmental cell·2025
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Sep 16, 2025

Induction and Analysis of Epithelial to Mesenchymal Transition
10:37

Induction and Analysis of Epithelial to Mesenchymal Transition

Published on: August 27, 2013

36.0K

Extracellular Vesicles Bearing Vimentin Drive Epithelial-Mesenchymal Transition.

Sepideh Parvanian1, Leila S Coelho-Rato2, Michael Santos Silva2

  • 1Center for Systems Biology, Massachusetts General Hospital Research Institute and Harvard Medical School, Boston, Massachusetts, USA; Turku Bioscience Centre, University of Turku and Åbo Akademi University, Turku, Finland; Faculty of Science and Engineering, Cell Biology, Åbo Akademi University, Turku, Finland.

Molecular & Cellular Proteomics : MCP
|July 6, 2025
PubMed
Summary

Extracellular vesicles carrying vimentin from fibroblasts drive epithelial-mesenchymal transition (EMT) in epithelial cells. Vimentin-positive vesicles promote EMT and wound healing, while vimentin-deficient vesicles do not.

Keywords:
epithelial–mesenchymal transitionextracellular vesiclesextracellular vimentinfibroblast

More Related Videos

Development of an In Vitro Assay to Evaluate Contractile Function of Mesenchymal Cells that Underwent Epithelial-Mesenchymal Transition
06:02

Development of an In Vitro Assay to Evaluate Contractile Function of Mesenchymal Cells that Underwent Epithelial-Mesenchymal Transition

Published on: June 10, 2016

12.3K
Molecular Analysis of Endothelial-mesenchymal Transition Induced by Transforming Growth Factor-β Signaling
07:49

Molecular Analysis of Endothelial-mesenchymal Transition Induced by Transforming Growth Factor-β Signaling

Published on: August 3, 2018

11.4K

Related Experiment Videos

Last Updated: Sep 16, 2025

Induction and Analysis of Epithelial to Mesenchymal Transition
10:37

Induction and Analysis of Epithelial to Mesenchymal Transition

Published on: August 27, 2013

36.0K
Development of an In Vitro Assay to Evaluate Contractile Function of Mesenchymal Cells that Underwent Epithelial-Mesenchymal Transition
06:02

Development of an In Vitro Assay to Evaluate Contractile Function of Mesenchymal Cells that Underwent Epithelial-Mesenchymal Transition

Published on: June 10, 2016

12.3K
Molecular Analysis of Endothelial-mesenchymal Transition Induced by Transforming Growth Factor-β Signaling
07:49

Molecular Analysis of Endothelial-mesenchymal Transition Induced by Transforming Growth Factor-β Signaling

Published on: August 3, 2018

11.4K

Area of Science:

  • Cell Biology
  • Biochemistry
  • Cancer Research

Background:

  • Epithelial-mesenchymal transition (EMT) is crucial in development, wound healing, and cancer.
  • Vimentin, an intermediate filament protein, is known to regulate EMT intracellularly.
  • Extracellular vimentin's role, particularly from extracellular vesicles (EVs), is an emerging area of research.

Purpose of the Study:

  • To investigate whether extracellular vimentin, specifically from fibroblast-derived EVs, regulates EMT.
  • To determine the role of vimentin in EVs in promoting EMT and associated cellular processes like wound healing.

Main Methods:

  • Utilized co-culture models of epithelial cells and fibroblasts.
  • Treated epithelial cells with EVs derived from wild-type and vimentin-knockout fibroblasts.
  • Performed proteomic profiling of wild-type and vimentin-deficient EVs.

Main Results:

  • Fibroblast-derived EVs induced an EMT phenotype in epithelial cells, characterized by altered epithelial and mesenchymal markers.
  • EVs from vimentin-deficient fibroblasts exhibited reduced EMT-inducing capacity and failed to promote cell cover closure.
  • Proteomic analysis revealed that wild-type EVs are enriched with EMT-associated proteins, including fibronectin and N-cadherin, which were diminished in vimentin-deficient EVs.

Conclusions:

  • Extracellular vimentin, delivered via fibroblast-derived EVs, is a critical driver of EMT.
  • Vimentin-positive EVs transmit specific protein cargo that facilitates EMT and wound healing.
  • Understanding the vimentin-positive EV proteome offers insights into EMT mechanisms and potential therapeutic targets for EMT-related pathologies.